Kapadia Sandip
Known title: CHIEF FINANCIAL OFFICERCIK: 0001677141
Associated companies
Transaction History
| HRMY | ▼ Sell | Open Market | 3,746 | $139K | 1/26/2026 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 4,725 | $0 | 1/25/2026 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 2,553 | $94K | 1/25/2026 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 3,813 | $0 | 1/24/2026 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 2,239 | $82K | 1/24/2026 | View on chart |
| HRMY | ▼ Sell | Open Market | 20,961 | $753K | 1/15/2026 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 20,000 | $581K | 12/5/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 20,000 | $791K | 12/5/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 3,427 | $120K | 11/21/2025 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 45,000 | $0 | 9/30/2025 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 24,039 | $663K | 9/30/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 21,573 | $787K | 8/15/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 6,247 | $203K | 4/1/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 740 | $25K | 4/1/2025 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 15,000 | $0 | 3/29/2025 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 8,014 | $266K | 3/29/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 1,775 | $68K | 1/27/2025 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 3,812 | $0 | 1/24/2025 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 2,037 | $77K | 1/24/2025 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 25,000 | $726K | 1/21/2025 | View on chart |
| HRMY | ▼ Sell | Open Market | 25,000 | $1.0M | 1/21/2025 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 60,000 | $0 | 9/30/2024 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 32,052 | $1.3M | 9/30/2024 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 15,000 | $0 | 3/29/2024 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 8,013 | $269K | 3/29/2024 | View on chart |
| HRMY | ▲ Buy | Option Exercise | 30,000 | $0 | 3/29/2023 | View on chart |
| HRMY | ▼ Sell | Tax Withholding | 15,414 | $514K | 3/29/2023 | View on chart |
| PASG | ▼ Sell | Open Market | 5,000 | $6K | 12/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
HRMY Reports New Phase 3 Data and Maintains Positive Analyst Outlook
HRMY shared new Phase 3 data at the European Narcolepsy Days, adding to its pipeline. Analysts remain upbeat, with Needham keeping a positive stance and a $50 target. The Wakix franchise also offers multiple value drivers. Shares rose 48% recently, yet the stock still trades below its 52‑week low.
HRMY Reports New Phase 3 Data and Maintains Positive Analyst Outlook. HRMY shared new Phase 3 data at the European Narcolepsy Days, adding to its pipeline. Analysts remain upbeat, with Needham keeping a positive stance and a $50 target. The Wakix franchise also offers multiple value drivers. Shares rose 48% recently, yet the stock still trades below its 52‑week low.